ACM
ACHV icon

Altium Capital Management’s Achieve Life Sciences ACHV Stock Holding History

Altium Capital Management’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-216,310
Closed -$1.02M – 80
2024
Q2 		$1.02M Sell
216,310
-619,160
-74% -$2.98M 0.41% 32
2024
Q1 		$3.8M Buy
+835,470
New +$3.71M 1.5% 23
2022
Q2 		– Sell
-122,000
Closed -$924K – 127
2022
Q1 		$924K Hold
122,000
– – 0.31% 84
2021
Q4 		$949K Hold
122,000
– – 0.26% 94
2021
Q3 		$1.04M Hold
122,000
– – 0.27% 95
2021
Q2 		$1.1M Buy
+122,000
New +$1.16M 0.25% 103

Other funds holding ACHV

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Altium Capital Management's ACHV Position: Q3 2024 in Review

Altium Capital Management sold out of Achieve Life Sciences (ACHV) in Q3 2024, closing a stake of 216,310 shares — an estimated $1.02M sold.

Altium Capital Management first reported a position in ACHV in Q2 2021 and held it in 6 quarters. The position peaked at $3.8M in Q1 2024. 64 funds tracked by Wall St. Rank hold ACHV as of Q3 2024.

  • Altium Capital Management reported no remaining Achieve Life Sciences position as of Q3 2024 after selling out during the quarter.
  • Altium Capital Management sold 216,310 Achieve Life Sciences shares in Q3 2024, an estimated $1.02M.
  • Altium Capital Management first reported a position in Achieve Life Sciences in Q2 2021 and held it in 6 quarters.
  • Altium Capital Management's Achieve Life Sciences position peaked at $3.8M in Q1 2024.
  • 64 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q3 2024.

Based on Altium Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.